Background illustration for clinical trials search

Paid Clinical Trials Indianapolis

Discover 901 paid clinical trials in Indianapolis, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Indianapolis IN, Louisville KY, Columbus OH,
Sponsor: Children's Oncology Group

Sex: All

Age: 2 - 18

Code: NCT05711667

Phase 3, Recruiting

Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

for
BRAF V600 Mutation, Low-grade Glioma, Low Grade Glioma of Brain,
Location: Indianapolis IN, St Louis MO, Memphis TN, Birmingham AL,
Sponsor: University of California, San Francisco

Sex: All

Age: 1 - 25

Code: NCT07110246

Phase 2, Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Indianapolis IN, Cincinnati OH, Chicago IL,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 21

Code: NCT04870944

Phase 1, Phase 2, Recruiting

I-DECIDE After Bronchiolitis Hospitalization

for
Bronchiolitis Acute
Location: Indianapolis IN, Cincinnati OH, Dayton OH, Chicago IL,
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT07243652

Recruiting

Cerebral Physiology of NOWS

for
Neonatal Opioid Withdrawal, Neonatal Opioid Withdrawal Syndrome,
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 0

Code: NCT07610746

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Minima Stent System Post- Approval Study (PAS)

for
Pulmonary Artery Stenosis, Aortic Coarctation
Location: Indianapolis IN, Cincinnati OH, Chicago IL, Columbus OH,
Sponsor: Renata Medical

Sex: All

Age: 0+

Code: NCT06828770

Recruiting

Non-invasive Prediction of EArly Cardiac rEjection

for
Heart Transplant, Pediatric Heart Transplant, Rejection,
Location: Indianapolis IN, Chicago IL, Columbus OH, Ann Arbor MI,
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 6 - 25

Code: NCT07770659

Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Indianapolis IN, Louisville KY, Niles MI,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase 3, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Indianapolis IN, Cincinnati OH, Dayton OH, Lexington KY,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

Optimal Ventilation for Cardiac Arrest

for
Cardiac Arrest (CA)
Location: Indianapolis IN, Cincinnati OH, Columbus OH,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT07114510

Recruiting

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

for
Neurofibromatosis 1, Plexiform Neurofibroma
Location: Indianapolis IN, Cincinnati OH, Chicago IL, St Louis MO,
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 1 - 8

Code: NCT06188741

Phase 2, Recruiting

Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials

for
Duchenne Muscular Dystrophy (DMD), Cardiomyopathy,
Location: Indianapolis IN, Chicago IL, Columbus OH, Nashville TN,
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 0+

Code: NCT07674758

Recruiting

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

for
Lymphoblastic Lymphoma, Acute Lymphoblastic Leukemia ALL
Location: Indianapolis IN, New York NY, Fort Worth TX, Houston TX,
Sponsor: Allterum Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT07586618

Phase 1, Recruiting

Bowel Continence Across the Lifespan in People With Spina Bifida

for
Spina Bifida, Neurogenic Bowel, Bowel Incontinence
Location: Indianapolis IN, Cincinnati OH, Chicago IL, Columbus OH,
Sponsor: David Chu

Sex: All

Age: 5+

Code: NCT07390318

Recruiting

Childhood Cancer Survivor Study

for
Cancer
Location: Indianapolis IN, Chicago IL, Columbus OH, Ann Arbor MI,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT01120353

Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Indianapolis IN, Cincinnati OH, Dayton OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase 2, Recruiting

Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections

for
Methicillin Resistant Staphylococcus Aureus,
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 0 - 18

Code: NCT06982105

Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Indianapolis IN, Cincinnati OH, Dayton OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase 2, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Indianapolis IN, Dayton OH, Lexington KY, Chicago IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase 2, Recruiting

Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placement and Initiation of Bowel Flush Regimen

for
Constipation
Location: Indianapolis IN, Carmel IN
Sponsor: Indiana University

Sex: All

Age: 2 - 18

Code: NCT05821309

Recruiting